Table 2.
Graded ocular symptoms and total ocular symptom score of 108 European COVID-19 non-hospitalized patients before versus during COVID-19 infection
| Graded ocular symptoms | Before COVID-19 | During COVID-19 | p value |
|---|---|---|---|
| Ocular itching, mean ± SD (range) | 0.05 ± 0.25 (range, 0–2) | 0.30 ± 0.67 (range, 0–3) | 0.001 |
| None, n (%) | 104 (96.3%) | 88 (81.5%) | — |
| Mild, n (%) | 3 (2.8%) | 9 (8.3%) | — |
| Moderate, n (%) | 1 (0.9%) | 10 (9.3%) | — |
| Severe, n (%) | 0 (0.0%) | 1 (0.9%) | — |
| Ocular redness, mean ± SD (range) | 0.06 ± 0.27 (range, 0–2) | 0.33 ± 0.64 (range, 0–3) | <0.001 |
| None, n (%) | 103 (95.4%) | 80 (74.1%) | — |
| Mild, n (%) | 4 (1.9%) | 22 (20.4%) | — |
| Moderate, n (%) | 1 (0.9%) | 4 (3.7%) | — |
| Severe, n (%) | 0 (0.0%) | 2 (1.9%) | — |
| Epiphora, mean ± SD (range) | 0.17 ± 0.42 (range, 0–2) | 0.45 ± 0.72 (range, 0–3) | <0.001 |
| None, n (%) | 92 (85.2%) | 71 (65.7%) | — |
| Mild, n (%) | 14 (13.0%) | 27 (25.0%) | — |
| Moderate, n (%) | 2 (1.9%) | 8 (7.4%) | — |
| Severe, n (%) | 0 (0.0%) | 2 (1.9%) | — |
| Eye swelling, mean ± SD (range) | 0.06 ± 0.31 (range, 0–2) | 0.19 ± 0.51 (range, 0–3) | 0.022 |
| None, n (%) | 103 (95.4%) | 93 (86.1%) | — |
| Mild, n (%) | 3 (2.8%) | 11 (10.2%) | — |
| Moderate, n (%) | 2 (1.9%) | 3 (2.8%) | — |
| Severe, n (%) | 0 (0.0%) | 1 (0.9%) | — |
| Total Ocular Symptom Score, mean ± SD (range) | 0.33 ± 1.04 (range, 0–8) | 1.27 ± 1.85 (range, 0–12) | <0.001 |